Literature DB >> 22470076

Health-related quality of life in disease-free survivors of surgically treated lung cancer compared with the general population.

Young Ho Yun1, Young Ae Kim, Young Hee Min, Yoon Jung Chang, Jongmog Lee, Moon Soo Kim, Hyun-Sung Lee, Jhingook Kim, Yong Soo Choi, Young Mog Shim, Jae Ill Zo.   

Abstract

OBJECTIVE: We compared the health-related quality of life (HRQOL) of disease-free lung cancer survivors with those from the general population.
BACKGROUND: Although clinical research usually is focused on how to better identify the lung patients most likely to benefit from surgery in terms of survival, few studies have concentrated specifically on HRQOL in disease-free lung cancer survivors compared with that of the general population.
METHODS: We enrolled 830 disease-free cancer survivors (median time since diagnosis, 4.11 years) who had a past diagnosis of lung cancer and treated with curative surgery (stage from 0 to III) at either of 2 hospitals between 2001 and 2006, and 1000 subjects without a history of cancer were selected randomly from a representative sample of general Korean population. Subjects filled out a questionnaire that included the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and the lung cancer module.
RESULTS: There were no clinically meaningful differences between the disease-free lung cancer survivors and general population in terms of any of the functioning subscales and most of the symptoms. However, survivors exhibited clinically meaningful worse dyspnea and financial problems on the EORTC QLQ-C30 subscales and dyspnea, coughing, and pain in chest wall on the EORTC QLQ-LC13 subscales than the general population. There was no clinically significant difference between the survivor groups according to the survival time. Survivors receiving lung resection, radiotherapy, and chemotherapy had clinically meaningful worse dyspnea than survivors receiving only lung resection. Lung cancer survivors with a respiratory or cardiologic comorbidity showed clinically meaningful worse social functioning, fatigue, dyspnea, and financial problems.
CONCLUSIONS: These findings afford useful information clinicians preparing patients for lung cancer treatment by providing them with an understanding of the potential outcomes, and also for potential intervention targeting supportive care needs.

Entities:  

Mesh:

Year:  2012        PMID: 22470076     DOI: 10.1097/SLA.0b013e31824f1e9e

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  10 in total

1.  Clinical significance of radiation dose-volume parameters and functional status on the patient-reported quality of life changes after thoracic radiotherapy for lung cancer: a prospective study.

Authors:  Byoung Hyuck Kim; Jin-Soo Kim; Ki Hwan Kim; Hyeon Jong Moon; Suzy Kim
Journal:  Radiol Med       Date:  2020-09-05       Impact factor: 3.469

2.  Danish population-based reference data for the EORTC QLQ-C30: associations with gender, age and morbidity.

Authors:  Therese Juul; Morten Aagaard Petersen; Bernhard Holzner; Søren Laurberg; Peter Christensen; Mogens Grønvold
Journal:  Qual Life Res       Date:  2014-03-28       Impact factor: 4.147

3.  Characterization of Dyspnea in Veteran Lung Cancer Survivors Following Curative-Intent Therapy.

Authors:  Duc Ha; Andrew L Ries
Journal:  J Cardiopulm Rehabil Prev       Date:  2020-03       Impact factor: 3.646

4.  Prognostic value of quality of life score in disease-free survivors of surgically-treated lung cancer.

Authors:  Young Ho Yun; Young Ae Kim; Jin Ah Sim; Ae Sun Shin; Yoon Jung Chang; Jongmog Lee; Moon Soo Kim; Young Mog Shim; Jae Lll Zo
Journal:  BMC Cancer       Date:  2016-07-20       Impact factor: 4.430

5.  Health-related Quality of Life Assessed by the EORTC QLQ-C30 Questionnaire in the General Slovenian Population.

Authors:  Vaneja Velenik; Ajra Secerov-Ermenc; Jasna But-Hadzic; Vesna Zadnik
Journal:  Radiol Oncol       Date:  2017-04-22       Impact factor: 2.991

6.  The major effects of health-related quality of life on 5-year survival prediction among lung cancer survivors: applications of machine learning.

Authors:  Jin-Ah Sim; Young Ae Kim; Ju Han Kim; Jong Mog Lee; Moon Soo Kim; Young Mog Shim; Jae Ill Zo; Young Ho Yun
Journal:  Sci Rep       Date:  2020-07-01       Impact factor: 4.379

7.  Predicting postoperative fatigue in surgically treated lung cancer patients in Norway: a longitudinal 5-month follow-up study.

Authors:  Therese Hugoy; Anners Lerdal; Tone Rustoen; Trine Oksholm
Journal:  BMJ Open       Date:  2019-09-27       Impact factor: 2.692

8.  Cancer Survivorship in Primary Care.

Authors:  Jihun Kang; Eun Ju Park; Jungkwon Lee
Journal:  Korean J Fam Med       Date:  2019-11-20

9.  Patient features predicting long-term survival and health-related quality of life after radical surgery for non-small cell lung cancer.

Authors:  Ville Rauma; Jarmo Salo; Harri Sintonen; Jari Räsänen; Ilkka Ilonen
Journal:  Thorac Cancer       Date:  2016-01-21       Impact factor: 3.500

10.  Factors related with colorectal and stomach cancer screening practice among disease-free lung cancer survivors in Korea.

Authors:  Sang Min Park; Jongmog Lee; Young Ae Kim; Yoon Jung Chang; Moon Soo Kim; Young Mog Shim; Jae Ill Zo; Young Ho Yun
Journal:  BMC Cancer       Date:  2017-08-30       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.